Ibogaine Football is an independent information resource on ibogaine for football players (active and retired), focused on concussion/CTE, chronic pain, recovery and life after the game. We collect, summarize and link to research, traveler experiences, and official materials so players can find audience-specific evidence without clinic marketing or partisan advocacy.
Mission
To provide plainspoken, evidence-first information tailored to football players exploring ibogaine-related options and questions.
Values
Independence · Plain language · Audience-specific evidence · No fabricated credentials
Our editorial approach
We publish summaries and guides about topics relevant to football players and ibogaine, and we keep our process transparent so readers can judge the evidence themselves. For editorial depth we draw on registries, peer-reviewed literature and official sources rather than marketing materials. For example, when describing program structures we compare registry notes and published protocols and link readers to specialized registries when appropriate.
Our review process favors verifiable sources: clinical registries where available, university literature reviews, and government health advisories. To underline how we vet items, we link to primary registries and summaries and note where evidence is limited or based on case reports rather than randomized trials. For context about evidence standards we sometimes reference broadly recognized resources such as the National Institutes of Health on how clinical evidence is graded (NIH research guidance).
We also maintain an internal index of topic pages and services; when readers want practical next steps we point to our structured listings such as pages on different treatment contexts — for example, our pages that review service options and international treatment discussions offer navigational pathways to /services/ and back to the site overview at / so the editorial trail is clear and traceable.
What we cover
Our content is organized around practical questions players ask after a career in football: how to read safety literature, pathways for follow-up care, harm-minimization for treatment-seeking, and the lived aspects of recovery and reintegration. Coverage is thematic and audience-focused rather than exhaustive pharmacology.
We maintain feature pages that summarize care contexts (domestic registries, international treatment, and aftercare). Where readers explore different treatment-setting options we provide links to descriptive directories such as institutional lists and travel-oriented summaries; for instance, readers sometimes consult clinic directories and international listings like those on specialized treatment portals to understand availability and cost considerations (treatment directory notes).
Because players ask about access and cost, our resource links to broad cost-overview pages for transparency; those overviews help readers form realistic expectations while keeping editorial distance from any provider's claims (an overview of cost factors).
How information is sourced and vetted
We source information from registries, peer-reviewed journals, official public-health guidance, and documented program descriptions. Where practical we link readers to registries or clinic summaries so they can inspect primary materials themselves; for instance, pages focused on comorbid conditions point to specialized resources such as clinic directories and treatment descriptions like those found on regional clinic summaries.
To support transparency about specialized applications, we include links to context-specific resources where readers may research related indications and facilities, for example directories discussing ibogaine use in other therapeutic contexts (clinical discussion on Parkinson's contexts) or for PTSD-related summaries (PTSD treatment summaries).
When we present program-level descriptions we seek registry confirmation and published follow-up when available. For readers exploring international options we include contextually relevant European listings to describe how provision differs regionally (European treatment listings).
We also point to high-level trusted sources that explain how medical evidence is formed, such as university methodology pages or government guidance; for an overview of clinical trial phases and evidence grading see the CDC's public health resources.
Editorial principles
Independence: We publish without financial ties to clinics or product vendors.
Plain language: Information is written to be accessible to players and their families.
Evidence-first: Claims are linked to registries or literature and flagged when evidence is limited.
Audience-focused: Content is tailored to football players' practical concerns — reintegration, chronic pain, and concussion-related questions.
If you want to explore service-related descriptions we maintain a services overview that links editorially to our topic pages; for a structured view of what service types exist and how we classify them, see our services summaries at services explained.
Who this is for
The primary audience is football players, both active and retired, and people supporting them. Our pages prioritize the specific concerns that arise from a career in contact sports: long-term brain health, chronic pain management, and transition planning after football.
For readers comparing treatment contexts, we link to informational directories and summaries rather than directly endorsing any provider; examples of directories we reference include international and domestic listings that aggregate program details and patient-reported notes.
Independent by design
Ibogaine Football is an independent information resource. It is not a clinic, medical provider, or licensed treatment center, and its content is not medical or legal advice. Readers should consult qualified professionals for personal medical decisions.
If you want to compare how different treatment types present themselves, our editorial pages summarize publicly available listings and program descriptions; for those researching options internationally we include links to regionally-focused resources and directories as context for travel and program structure.
FAQ highlights
Why focus on football players?
The physical and neurological exposures associated with football create specific questions about recovery and long-term health; this resource narrows the scope so readers get practical, audience-relevant evidence instead of general-interest summaries. For broader clinical framing on injury and long-term outcomes, public health resources such as university reviews and governmental summaries can help establish context (CTE overview on Wikipedia).
Do you endorse clinics?
No. We summarize publicly available program descriptions and link to directories or registries for transparency, but we do not endorse individual clinics or practitioners. Readers often consult directories to compare offerings and costs; editors maintain links to cost-overview resources to support budgetary planning (cost overview resources).
How can readers verify source material?
Every factual assertion that materially affects decisions points to transparent source material where possible: registry entries, peer-reviewed articles, and government guidance. We encourage readers to check cited registries and official advisories for primary data; for protocol and treatment-context examples we sometimes link to clinic summaries so readers can compare program descriptions (regional program summaries).
Can you help find a clinic?
We do not operate referrals. Our editorial pages describe service types and link to directories and directories that aggregate treatment models; to evaluate facilities independently readers consult those listings and external registries such as curated directories used widely in the field (treatment directories).
